BioSpace News Archive

Zealand Pharma today announced it will present four posters at the 2021 European Society for Clinical Nutrition and Metabolism (ESPEN) Virtual Congress, which is being held September 9-14, 2021.

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today presented data at the International Conference on Complement Therapeutics (ICCT), being held September 8-13, 2021.

Monopar Therapeutics Inc. today announced that Chandler D. Robinson, MD, Chief Executive Officer, is scheduled to present a Company overview at the following investor conferences in September: H.C. Wainwright 23rd Annual Global Investment Conference

Global Blood Therapeutics, Inc. announced that on September 1, 2021, the compensation committee of GBT’s board of directors granted 20 new employees options to purchase an aggregate of 49,600 shares of the company’s common stock with a per share exercise price of $29.85 and restricted stock units for an aggregate of 79,910 shares of the company’s common stock.

Krystal Biotech Inc. today announced that it will present data on its lead product candidate beremagene geperpavec (B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB) at the upcoming DEBRA International Conference 2021.

Applied Genetic Technologies Corporation (Nasdaq: AGTC), today announced that Jill Dolgin, PharmD, Executive Director of Global Patient Advocacy, and Halley Losekamp, Director of Patient Enrollment, will participate as speakers at the Clinical Trials in Rare Diseases Conference,

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo culture system (IVC), INVOcell®, an affordable and effective infertility treatment, announced today that it has completed the acquisition of a Canadian-based entity that was originally formed to offer INVOcell in Canada.

Inspira Technologies today announced that Joe Hayon , the Company’s Co-Founder and Chief Financial Officer, will participate virtually in the following upcoming conferences: H.C. Wainwright 23rd Annual Global Investment Conference

Gaumard Scientific Co., today commented on the recent findings published in Obstetrics and Gynecology documenting a reduction of malpractice claims rates by obstetrician-gynecologists who participated in medical simulation training.

Seagen Inc. (Nasdaq: SGEN) today announced that management will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 2:00 p.m. Eastern Time.